drugset / Trial / NCT00334646
Cyclophosphamide Drug Interaction Study In Cancer Patients
RandomizedCrossoverOpen-labelTreatment
Summary
This study is designed to evaluate the potential pharmacokinetic interaction between oral GW679769 and IV (intravenous) cyclophosphamide when administered to cancer patients.
Timeline
- Start
- 2005-08-10
- Primary completion
- 2009-10-14
- Completion
- 2009-10-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Casopitant | Small molecule | 150 mg | Oral |
| Subject | Cyclophosphamide | Other / unclassified | 500 mg/m2 | Intravenous |
| Subject | Cyclophosphamide | Other / unclassified | 700 mg/m2 | Intravenous |